Parathyroidectomy is the surgery to remove one or more of the parathyroid glands in the patient who has hyperparathyroidism with a varies of etiology. Parathyroidectomy is the only definitive treatment for primary hyperparathyroidism. The majority of patients with primary hyperparathyroidism have a single parathyroid adenoma. The traditional parathyroidectomy is to explore all four glands and remove the adenoma(s).
With the development of the preoperative localization technique, the minimally invasive surgery using the radio-guided technique, ultrasound imaging, high-resolution endoscopic technique, rapid intraoperative parathyroid hormone (IOPTH) monitoring has been used by many surgeons. The traditional parathyroidectomy still has its advantages and is the standard surgery that is reviewed in this article.[1][2][3][4]
The parathyroid glands are 4 glands located posterior to the thyroid, weighted 30-50 mg. The 2 superior parathyroid glands are derived from the fourth pharyngeal pouch, more constant located in the neck, posterior to the recurrent laryngeal nerve. The 2 inferior parathyroid glands are derived from the third pharyngeal pouch as well as thymus, they are mostly located inferior to the thyroid and anterior to the recurrent laryngeal nerve, but sometimes they can migrate to the lower neck or behind the sternum. The Ectopic glands may be located in carotid sheath, paraesophageal or intrathyroidal position.
The 4 parathyroid glands are supplied by the inferior thyroid artery from the thyrocervical trunk. The superior parathyroid glands may be supplied by the superior thyroid artery or by an anastomotic branch between the inferior thyroid and the superior thyroid artery in 20% of cases.
Parathyroid glands regulate the calcium by secreting Parathyroid Hormone (PTH). When the serum calcium level decreases, the chief cells in parathyroid release PTH. In the kidney, PTH increases calcium re-absorption, excretion of phosphate, and promotes 25-hydroxy vitamin D converting to active 1,25-dihydroxy Vitamin D-3. In the bone, PTH stimulates osteoclast activity and release calcium into the blood and elevates serum calcium level. In the intestine, activated Vitamin D increases the absorption of the calcium.
Hyperparathyroidism is a disorder with excessive production of PTH due to the overactivity of the parathyroid gland. Primary hyperparathyroidism is caused by autonomous hypersecretion of PTH from the abnormal parathyroid gland. The majority of patients with primary hyperparathyroidism have a single enlarged parathyroid gland, mostly adenoma. In rare cases, multiple endocrine neoplasia (MEN) type 1, type 2A, or parathyroid carcinoma can cause primary hyperparathyroidism. The high level of calcium due to hypersecretion of PTH can lead to neuromuscular symptoms, osteoporosis and bone loss, and kidney stones.
Secondary hyperparathyroidism is due to high PTH levels from the physiological response to hypocalcemia. Vitamin D deficiency and chronic renal failure are the most common causes of secondary hyperparathyroidism.
Tertiary hyperparathyroidism occurs in patients with secondary hyperparathyroidism from chronic renal failure and persistent secretion of PTH after renal transplant.
Primary Hyperparathyroidism
Parathyroidectomy is indicated for all the patients with symptomatic primary hyperparathyroidism.[5] The symptoms include polydipsia and polyuria, Nephrolithiasis or nephrocalcinosis, hypercalciuria (24-hour urine calcium level >400 mg/dL), Impaired renal function (glomerular filtration rate [GFR] <60 mL/minute), Osteoporosis (bone density score <-2.5), fragility fracture or vertebral compression fracture, pancreatitis, peptic ulcer disease or gastroesophageal reflux and neurocognitive dysfunction or neuropsychiatric symptoms attributable to PHPT.
Indications of Parathyroidectomy in Asymptomatic Hyperparathyroidism[6]
Age younger than 50 years, Serum calcium level >1 mg/dL above the normal limit, Urinary calcium excretion > 400 mg per 24 hours (10 mmol per day), Creatinine clearance reduced by more than 30 percent compared with age-matched persons, Bone density (lumbar spine, hip, or forearm) that is > 2.5 standard deviations below peak bone mass (T score -2.5), Medical surveillance not desirable or possible, and Surgery requested by the patient.
A recent study revealed normocalcemic and hypercalcemic primary hyperparathyroidism had similarly increased cardiovascular risk factors. Parathyroidectomy ameliorated the increased cardiovascular risk factors in both normocalcemic and hypercalcemic PHPT.[7]
Secondary Hyperparathyroidism
Patients with secondary hyperparathyroidism are usually managed medically. Parathyroidectomy is indicated in the refractory hyperparathyroidism with hypercalcemia or hyperphosphatemia or severe symptoms. About 15% of patients will need parathyroidectomy for medically refractory secondary hyperparathyroidism after 5 to 10 years on dialysis.[8]
Tertiary Hyperparathyroidism
Tertiary hyperparathyroidism with symptomatic hypercalcemia is the main indication for parathyroidectomy. Surgical treatment for tertiary HPT has higher cure rates than medical therapy.[9] Limited or subtotal parathyroidectomy is recommended. The goal is a normal calcium level at least 6 months postoperatively.[10]
Parathyroidectomy is indicated if the hyperparathyroidism is suspicion of parathyroid carcinoma, especially with significantly elevated calcium or PTH levels, painful large neck mass, or inhomogeneous mass on imaging.[5]
Other indications of parathyroidectomy include parathyroid cyst, parathyroid hypercalcemic crisis (severe hypercalcemia and central nervous system dysfunction).[11][12]
Absolute Contraindication
Parathyroidectomy is contraindicated in patients with familial hypocalciuric hypercalcemia (FHH) presenting with elevated calcium and PTH levels but low 24-hour urine calcium excretion and a low ratio of 24-hour urinary calcium to creatinine clearance. Parathyroidectomy does not cure FHH -associated hypercalcemia.[13]
Relative Contraindication
Contralateral recurrent laryngeal nerve (RLN) injury or vocal cord dysfunction.
The following equipment is needed:
Standard operating room staff, one or two surgeons, and the anesthesiologist.
Surgery Plan
Parathyroidectomy is the standard treatment for hyperparathyroidism. The goal is to remove the parathyroid gland or glands producing excess PTH. For patients with the multi-gland disease, unsuccessful preoperative localization, the traditional surgical approach of bilateral parathyroid exploration of 4 glands is the standard procedure. Focused parathyroidectomy with a smaller incision and less dissection is used in patients with a well-localized solitary adenoma. Compared to bilateral parathyroid exploration, focused parathyroidectomy has similar clinical outcomes: including recurrence, persistence, and reoperation rates but significantly lower overall complication rates and shorter operative time.[16]
Total parathyroidectomy and subtotal parathyroidectomy (a small remnant of gland left or auto-transplanted) are indicated in secondary or tertiary hyperparathyroidism with parathyroid hyperplasia. Total parathyroidectomy with auto-transplantation carries a higher risk of permanent hypocalcemia and cardiovascular events whereas the risk of hyperparathyroidism recurrence is higher with subtotal parathyroidectomy.[8] [17] Several new technologies including ultrasound localization, of hyperplastic parathyroid glands, radio-guided surgery, endoscopic-assisted parathyroidectomy, and intraoperative assessment of serum PTH levels can be appropriately used in the practice of parathyroid surgery.[18]
Preoperative Localization
Preoperative localization is critical for focused, minimally invasive parathyroid surgery. The localization imaging studies include Sestamibi scintigraphy (technetium-99-sestamibi scanning), SPECT — Sestamibi-single photon emission computed tomography (SPECT or MIBI-SPECT), SPECT and CT fusion, neck ultrasound, 4D-CT, MRI, and PET-CT.[19][20] In the cases with a history of neck surgery, unsuccessful radio-image localization, invasive localization such as selective venous sampling.[21][22]
Pre-op Preparation
Anesthesia
General anesthesia is preferred for parathyroidectomy, especially for the patients who need sternotomy, neck dissection. Most surgeons prefer to use general anesthesia with intubation for single gland, focused parathyroidectomy.[23] Recent studies showed local anesthesia with the cervical block is feasible, and significantly reduce the cost.[24] Local anesthesia in minimally invasive parathyroidectomy was associated with significantly lower postoperative pain, nausea, and vomiting.[25] General anesthesia is preferred for parathyroidectomy, especially for the patients who need sternotomy, neck dissection.
Position
The patient is placed on the operating table in a supine position with the neck extended and both arms tucked at the sides. A shoulder roll can be placed to improve the exposure of the neck. The operating table is slightly placed in reverse Trendelenburg position. Patients with cervical spine disease should be assessed for the safety of neck extension.
Procedure
Intraoperative Decision Making
Postoperative Neck Bleeding and Hematoma
Postoperatively life-threatening hematoma is rare, the incidence reported was 0.6%.[29] But it is a serious complication. The hematoma compresses the trachea, causes venous congestion of airway structures, and subsequent airway compromise. Immediate wound opening and surgical hematoma evacuation or re-exploration are indicated to alleviate airway compression. Intubation should not be delayed.
Recurrent Laryngeal Nerve Injury
Recurrent laryngeal nerve injury is one of the most feared complications of parathyroid surgery. Injury to the recurrent laryngeal nerve results in paresis or palsy of the vocal cord causing hoarseness (unilateral damage) or stridor, airway occlusion (bilateral damage), and an increased risk of aspiration, may need immediate reintubation or occasionally tracheostomy. Most recurrent laryngeal nerve injuries are transient. 1.1% of the patient presented a permanent postoperative vocal cord paresis after thyroid and parathyroid surgery due to recurrent laryngeal nerve injury. Injuries after parathyroidectomy are less frequent compared to thyroid surgery. Most of the patients with transient postoperative recurrent laryngeal nerve injury recovered normal vocal cord mobility within 6 months.[30] Identifying the recurrent laryngeal nerve during thyroid dissection is the gold standard to avoid nerve injury.[31]
Intraoperative nerve monitoring during parathyroidectomy is a promising adjunct to visualization alone in detecting nerve structures during neck dissection, which may decrease the likelihood of recurrent laryngeal nerve injury.[32] A reinnervation procedure should be attempted When recurrent laryngeal nerve transection is recognized during parathyroidectomy.[5]
Hypoparathyroidism and Hypocalcemia
The symptoms of postoperative hypocalcemia include perioral numbness, fingertip paresthesia, Chvostek’s sign, Trousseau’s sign, and severe symptoms including tetany, cardiac dysrhythmia, seizures. Most hypocalcemia is transient, and permanent hypocalcemia is reported in only 0.5% to 3.8% of cases.[33] One of the most common causes of postsurgical hypoparathyroidism and hypocalcemia is inadvertent removal of, damage to, or inadvertent devascularization of the parathyroid glands. Postoperative hypocalcemia may be due to “Hungry bone syndrome” with low serum calcium levels resulting from remineralization of the bone as the stimulus of PTH for high bone turnover is removed after parathyroid surgery.[34] As the American Association of Endocrine Surgeons Guidelines recommendation, patients with transient postoperative hypoparathyroidism should be treated with calcium and, if necessary, calcitriol supplements, which should be weaned as tolerated. Patients with prolonged hypoparathyroidism may be considered for recombinant PTH therapy.[5]
Persistent or Recurrent Hyperparathyroidism
Persistent/recurrent hyperparathyroidism occurs in 2% to 5% of patients with sporadic primary hyperparathyroidism.[35] Persistent hyperparathyroidism should be defined as a failure to achieve normocalcemia within6months of parathyroidectomy. Recurrent hyperparathyroidism is defined by the recurrence of hypercalcemia after a normocalcemic interval at more than 6 months after parathyroidectomy.[5]
The most common causes of persistent/recurrent hyperparathyroidism include unrecognized four gland hyperplasia, ectopic location of the hyperfunctioning parathyroid gland(s), or operations performed by inexperienced or low-volume parathyroid surgeons.[36][37] A final intraoperative PTH level greater than 40 pg/mL was associated with an increased risk of persistent and recurrent disease irrespective of the number of glands resected.[35]
The subsequent operation for persistent or recurrent hyperparathyroidism is often recommended to achieve biochemical cure. But the indication is stricter than initial surgery due to lower cure rates and higher risks in the subsequent operation. Preop evaluation should be made by an experienced parathyroid surgeon, including confirmation of biochemical diagnosis, assessment of indications for surgery, review of prior records if available, and evaluation of RLN function.[5]
Parathyroidectomy is the definitive therapy for primary hyperparathyroidism, may also be required in secondary or tertiary hyperparathyroidism. The bilateral neck exploration is the standard operation, especially optimal for patients who have multiple gland disease. With the improvement of the preoperative localization techniques and intraoperative PTH monitoring, minimally invasive parathyroidectomy is widely used in unilateral exploration. Even a four-gland exploration can be performed in a minimally invasive fashion.[38]
Parathyroidectomy involves a multidisciplinary team to achieve the best clinical outcome. The team includes surgeons, radiologists, pathologists, anesthesiologists, operating room nursing staff. This joint patient management minimizes the delay from diagnosing to operation decision, leading to efficient pre-operative imaging localization, ensure patient suitability for surgery, managing intraoperative nerve monitoring and PTH level monitor and optimize the postoperative care.
Nurses have an important role in the support, education, and care of the patients undergoing parathyroidectomy. Preoperative nursing interventions involve routing nursing physiological observations, offering patients psychological support and education about disease and surgery.
Nurses are especially crucial in postoperative patient safety involving hemodynamical monitoring, fluid balance, and electrolyte measurement. In particular, nurses must be aware of potential postoperative complications, including signs of recurrent laryngeal nerve injury, signs of hypocalcemia, neck hematoma. If the patient is discharged with medication, especially opioids, the nurse needs to review these medications with the patient for safety purposes.
[1] | Lee WJ,Ruda J,Stack BC Jr, Minimally invasive radioguided parathyroidectomy using intraoperative sestamibi localization. Otolaryngologic clinics of North America. 2004 Aug; [PubMed PMID: 15262516] |
[2] | Meilstrup JW, Ultrasound examination of the parathyroid glands. Otolaryngologic clinics of North America. 2004 Aug; [PubMed PMID: 15262514] |
[3] | Lo CY,Chan WF,Luk JM, Minimally invasive endoscopic-assisted parathyroidectomy for primary hyperparathyroidism. Surgical endoscopy. 2003 Dec; [PubMed PMID: 14574548] |
[4] | Khafif A,Pivoarov A,Medina JE,Avergel A,Gil Z,Fliss DM, Parathyroid hormone: a sensitive predictor of hypocalcemia following total thyroidectomy. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2006 Jun; [PubMed PMID: 16730528] |
[5] | Wilhelm SM,Wang TS,Ruan DT,Lee JA,Asa SL,Duh QY,Doherty GM,Herrera MF,Pasieka JL,Perrier ND,Silverberg SJ,Solórzano CC,Sturgeon C,Tublin ME,Udelsman R,Carty SE, The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA surgery. 2016 Oct 1; [PubMed PMID: 27532368] |
[6] | Bilezikian JP,Khan AA,Potts JT Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. The Journal of clinical endocrinology and metabolism. 2009 Feb; [PubMed PMID: 19193908] |
[7] | Beysel S,Caliskan M,Kizilgul M,Apaydin M,Kan S,Ozbek M,Cakal E, Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC cardiovascular disorders. 2019 May 8; [PubMed PMID: 31068134] |
[8] | Lau WL,Obi Y,Kalantar-Zadeh K, Parathyroidectomy in the Management of Secondary Hyperparathyroidism. Clinical journal of the American Society of Nephrology : CJASN. 2018 Jun 7; [PubMed PMID: 29523679] |
[9] | Dulfer RR,Franssen GJH,Hesselink DA,Hoorn EJ,van Eijck CHJ,van Ginhoven TM, Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. The British journal of surgery. 2017 Jun; [PubMed PMID: 28518414] |
[10] | Tang JA,Friedman J,Hwang MS,Salapatas AM,Bonzelaar LB,Friedman M, Parathyroidectomy for tertiary hyperparathyroidism: A systematic review. American journal of otolaryngology. 2017 Sep - Oct; [PubMed PMID: 28735762] |
[11] | McCoy KL,Yim JH,Zuckerbraun BS,Ogilvie JB,Peel RL,Carty SE, Cystic parathyroid lesions: functional and nonfunctional parathyroid cysts. Archives of surgery (Chicago, Ill. : 1960). 2009 Jan; [PubMed PMID: 19153325] |
[12] | Cannon J,Lew JI,Solórzano CC, Parathyroidectomy for hypercalcemic crisis: 40 years' experience and long-term outcomes. Surgery. 2010 Oct; [PubMed PMID: 20800863] |
[13] | Mrgan M,Nielsen S,Brixen K, Familial hypocalciuric hypercalcemia and calcium sensing receptor. Acta clinica Croatica. 2014 Jun; [PubMed PMID: 25163238] |
[14] | Angelos P, Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. The Surgical clinics of North America. 2009 Oct; [PubMed PMID: 19836490] |
[15] | Yarbrough DE,Thompson GB,Kasperbauer JL,Harper CM,Grant CS, Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. Surgery. 2004 Dec; [PubMed PMID: 15657563] |
[16] | Jinih M,O'Connell E,O'Leary DP,Liew A,Redmond HP, Focused Versus Bilateral Parathyroid Exploration for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. Annals of surgical oncology. 2017 Jul; [PubMed PMID: 27896505] |
[17] | Isaksson E,Ivarsson K,Akaberi S,Muth A,Prütz KG,Clyne N,Sterner G,Almquist M, Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery. 2019 Jan; [PubMed PMID: 30413319] |
[18] | Terris DJ,Stack BC Jr,Gourin CG, Contemporary parathyroidectomy: exploiting technology. American journal of otolaryngology. 2007 Nov-Dec; [PubMed PMID: 17980774] |
[19] | Bunch PM,Kelly HR, Preoperative Imaging Techniques in Primary Hyperparathyroidism: A Review. JAMA otolaryngology-- head [PubMed PMID: 30193297] |
[20] | Lee GS,McKenzie TJ,Mullan BP,Farley DR,Thompson GB,Richards ML, A Multimodal Imaging Protocol, (123)I/(99)Tc-Sestamibi, SPECT, and SPECT/CT, in Primary Hyperparathyroidism Adds Limited Benefit for Preoperative Localization. World journal of surgery. 2016 Mar; [PubMed PMID: 26732668] |
[21] | Ibraheem K,Toraih EA,Haddad AB,Farag M,Randolph GW,Kandil E, Selective parathyroid venous sampling in primary hyperparathyroidism: A systematic review and meta-analysis. The Laryngoscope. 2018 Nov; [PubMed PMID: 29756350] |
[22] | Taslakian B,Trerotola SO,Sacks B,Oklu R,Deipolyi A, The Essentials of Parathyroid Hormone Venous Sampling. Cardiovascular and interventional radiology. 2017 Jan; [PubMed PMID: 27796535] |
[23] | Greene AB,Butler RS,McIntyre S,Barbosa GF,Mitchell J,Berber E,Siperstein A,Milas M, National trends in parathyroid surgery from 1998 to 2008: a decade of change. Journal of the American College of Surgeons. 2009 Sep; [PubMed PMID: 19717037] |
[24] | Sen S,Cherian AJ,Ramakant P,Reka K,Paul MJ,Abraham DT, Focused Parathyroidectomy Under Local Anesthesia - A Feasibility Study. Indian journal of endocrinology and metabolism. 2019 Jan-Feb; [PubMed PMID: 31016156] |
[25] | Black MJ,Ruscher AE,Lederman J,Chen H, Local/cervical block anesthesia versus general anesthesia for minimally invasive parathyroidectomy: what are the advantages? Annals of surgical oncology. 2007 Feb; [PubMed PMID: 17122989] |
[26] | Jason DS,Balentine CJ, Intraoperative Decision Making in Parathyroid Surgery. The Surgical clinics of North America. 2019 Aug; [PubMed PMID: 31255199] |
[27] | Casella C,Galani A,Totaro L,Ministrini S,Lai S,Dimko M,Portolani N, Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience. International journal of endocrinology. 2018; [PubMed PMID: 30123263] |
[28] | Ippolito G,Palazzo FF,Sebag F,De Micco C,Henry JF, Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. The British journal of surgery. 2007 May; [PubMed PMID: 17380564] |
[29] | Rosenbaum MA,Haridas M,McHenry CR, Life-threatening neck hematoma complicating thyroid and parathyroid surgery. American journal of surgery. 2008 Mar; [PubMed PMID: 18241836] |
[30] | Joliat GR,Guarnero V,Demartines N,Schweizer V,Matter M, Recurrent laryngeal nerve injury after thyroid and parathyroid surgery: Incidence and postoperative evolution assessment. Medicine. 2017 Apr; [PubMed PMID: 28445266] |
[31] | Steurer M,Passler C,Denk DM,Schneider B,Niederle B,Bigenzahn W, Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk. The Laryngoscope. 2002 Jan; [PubMed PMID: 11802050] |
[32] | Ghani U,Assad S,Assad S, Role of Intraoperative Nerve Monitoring During Parathyroidectomy to Prevent Recurrent Laryngeal Nerve Injury. Cureus. 2016 Nov 15; [PubMed PMID: 28003944] |
[33] | Steen S,Rabeler B,Fisher T,Arnold D, Predictive factors for early postoperative hypocalcemia after surgery for primary hyperparathyroidism. Proceedings (Baylor University. Medical Center). 2009 Apr; [PubMed PMID: 19381311] |
[34] | Witteveen JE,van Thiel S,Romijn JA,Hamdy NA, Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. European journal of endocrinology. 2013 Mar; [PubMed PMID: 23152439] |
[35] | Mazotas IG,Yen TWF,Doffek K,Shaker JL,Carr AA,Evans DB,Wang TS, Persistent/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role? The Journal of surgical research. 2020 Feb; [PubMed PMID: 31635835] |
[36] | Chen H,Wang TS,Yen TW,Doffek K,Krzywda E,Schaefer S,Sippel RS,Wilson SD, Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Annals of surgery. 2010 Oct; [PubMed PMID: 20881776] |
[37] | Gough I, Reoperative parathyroid surgery: the importance of ectopic location and multigland disease. ANZ journal of surgery. 2006 Dec; [PubMed PMID: 17199687] |
[38] | Sosa JA,Udelsman R, Minimally invasive parathyroidectomy. Surgical oncology. 2003 Aug; [PubMed PMID: 12946483] |